BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer

Go back to BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
Clearview Acquisitions, Inc. (NASDAQ: CVAC) Delayed: 4.66 --0 (-0%)
Previous Close $4.66    52 Week High $2.10 
Open $4.66    52 Week Low $1.50 
Day High $4.66    P/E N/A 
Day Low $4.66    EPS $-0.04 
Volume 4,864,005